Stock BCT BRIACELL THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BriaCell Therapeutics Corp.

Equities

BCT

CA1079301091

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.87 CAD -4.59% Intraday chart for BriaCell Therapeutics Corp. -38.49% -76.03%
May. 15 BriaCell Therapeutics Prices $5 Million Offering; Shares Tumble MT
Apr. 24 BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting MT

Evolution of the average Target Price on BriaCell Therapeutics Corp.

Price target over the last 5 years

History of analyst recommendation changes

9b45cf6207.yZRo1DyIMutvnXYMl2BaE7til7-XbJ_UPqdpDq8fgBs.iq03vGvDUaEp90RFwCspK-ET2sj7DciRaJAlN_Bb2iyIuQORf-Zr3R3TAQ~7589f50517bb6f273291c55b2276ba00

Analyst Recommendations on BriaCell Therapeutics Corp.

BriaCell Has Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients MT
BriaCell Brief: Has Reported 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients; Comes After Shares Jumped 18% on Wednesday MT
BriaCell Therapeutics Corp. Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients CI
HC Wainwright Adjusts BriaCell Therapeutics' Price Target to $20 From $24.85, Keeps Buy Rating MT
HC Wainwright Initiates BriaCell Therapeutics at Buy With $25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.87
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering BriaCell Therapeutics Corp.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BCT Stock
  4. Consensus BriaCell Therapeutics Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW